HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nan Hu Selected Research

Therapeutics

4/2024The status of nuclear medicine in China: the first official national survey.
1/2024A regimen based on the combination of trimethoprim/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital.
1/2024Sonrotoclax overcomes BCL2 G101V mutation-induced venetoclax resistance in preclinical models of hematologic malignancy.
1/2024Platelet Membrane-Encapsulated Nanocomplexes Based on Profundity Scavenging ROS Strategy for Myocardial Infarction Therapy.
12/2023An Ultrasmall Cu/Cu2O Nanoparticle-Based Diselenide-Bridged Nanoplatform Mediating Reactive Oxygen Species Scavenging and Neuronal Membrane Enhancement for Targeted Therapy of Ischemic Stroke.
11/2023Single-cell RNA sequencing indicates cordycepin remodels the tumor immune microenvironment to enhance TIGIT blockade's anti-tumor effect in colon cancer.
11/2023Risk factor analysis of refracture in the same cemented vertebra after percutaneous kyphoplasty for Kümmell's disease.
1/2023Discovery of BGB-8035, a Highly Selective Covalent Inhibitor of Bruton's Tyrosine Kinase for B-Cell Malignancies and Autoimmune Diseases.
1/2023A public resource of baseline data from the Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial.
1/2023A bionic "Trojan horse"-like gene delivery system hybridized with tumor and macrophage cell membrane for cancer therapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nan Hu Research Topics

Disease

101Neoplasms (Cancer)
05/2024 - 02/2002
29Esophageal Squamous Cell Carcinoma
05/2024 - 01/2003
17Inflammation (Inflammations)
02/2024 - 01/2011
17Breast Neoplasms (Breast Cancer)
01/2022 - 08/2010
14Alzheimer Disease (Alzheimer's Disease)
01/2023 - 01/2013
13Stomach Neoplasms (Stomach Cancer)
11/2022 - 12/2009
12Carcinogenesis
03/2024 - 07/2006
12Fibrosis (Cirrhosis)
11/2023 - 04/2011
11Infections
03/2024 - 06/2009
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2024 - 06/2012
10Neoplasm Metastasis (Metastasis)
04/2024 - 10/2010
10Obesity
09/2023 - 01/2013
9Diabetes Mellitus
04/2024 - 03/2011
8Rheumatoid Arthritis
04/2024 - 01/2017
7Cognitive Dysfunction
12/2023 - 03/2014
7Hypoxia (Hypoxemia)
01/2023 - 01/2012
7Carcinoma (Carcinomatosis)
12/2022 - 02/2002
7Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 04/2011
6Myocardial Infarction
01/2024 - 11/2017
6Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2020
6Colitis
01/2021 - 05/2015
5Osteoporosis
03/2024 - 05/2017
5Thrombosis (Thrombus)
12/2023 - 09/2015
5Ulcerative Colitis
01/2021 - 05/2015
5Hypertension (High Blood Pressure)
01/2019 - 10/2012
5Mitochondrial Diseases (Mitochondrial Disease)
01/2018 - 02/2010
5Adenocarcinoma
10/2017 - 10/2011
4B-Cell Lymphoma (Lymphoma, B Cell)
05/2024 - 06/2013
4Hepatocellular Carcinoma (Hepatoma)
04/2024 - 12/2016
4Colonic Neoplasms (Colon Cancer)
11/2023 - 10/2016
4Hyperglycemia
09/2023 - 01/2012
4Insulin Resistance
09/2023 - 05/2014
4Wounds and Injuries (Trauma)
01/2023 - 10/2009
4Pain (Aches)
01/2023 - 10/2014
4Edema (Dropsy)
11/2022 - 11/2017
4Disease Progression
11/2022 - 03/2006
4Hepatitis B
06/2022 - 04/2011
4Hypertrophy
01/2022 - 04/2012
4Spinal Cord Injuries (Spinal Cord Injury)
01/2022 - 01/2016
4Ischemia
01/2022 - 02/2010
4Cardiomegaly (Heart Hypertrophy)
12/2021 - 02/2013
4Leukemia
01/2021 - 09/2009
4Cicatrix (Scar)
01/2021 - 05/2014
4Necrosis
11/2014 - 06/2013
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
05/2024 - 02/2017
3Stroke (Strokes)
04/2024 - 01/2021
3Bone Resorption
03/2024 - 01/2019
3Chronic Renal Insufficiency
10/2023 - 07/2022

Drug/Important Bio-Agent (IBA)

47Proteins (Proteins, Gene)FDA Link
05/2024 - 02/2002
32Biomarkers (Surrogate Marker)IBA
04/2024 - 03/2006
20Messenger RNA (mRNA)IBA
02/2024 - 09/2004
16DNA (Deoxyribonucleic Acid)IBA
06/2022 - 01/2003
13RNA (Ribonucleic Acid)IBA
11/2023 - 09/2004
13MicroRNAs (MicroRNA)IBA
01/2023 - 08/2010
9AntioxidantsIBA
02/2024 - 04/2011
7CytokinesIBA
02/2024 - 07/2014
7Reactive Oxygen Species (Oxygen Radicals)IBA
12/2023 - 02/2010
7Peptides (Polypeptides)IBA
08/2023 - 01/2010
7EnzymesIBA
01/2022 - 02/2009
6Adenosine Triphosphate (ATP)IBA
01/2024 - 12/2016
6Dextran SulfateIBA
01/2021 - 05/2015
5Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
05/2023 - 02/2009
5ErbB Receptors (EGF Receptor)IBA
06/2022 - 01/2013
5Streptozocin (Streptozotocin)FDA Link
01/2022 - 03/2011
5CollagenIBA
01/2022 - 01/2021
5ORALIT (ORS)IBA
09/2021 - 04/2015
4Anti-Bacterial Agents (Antibiotics)IBA
04/2024 - 06/2009
4Agammaglobulinaemia Tyrosine KinaseIBA
01/2023 - 02/2017
4Phosphotransferases (Kinase)IBA
01/2023 - 03/2013
4Small Interfering RNA (siRNA)IBA
12/2022 - 01/2014
4Complement System Proteins (Complement)IBA
10/2022 - 08/2010
4Mitochondrial Aldehyde DehydrogenaseIBA
01/2022 - 01/2012
4Interleukin-6 (Interleukin 6)IBA
12/2021 - 06/2013
4Glucose (Dextrose)FDA LinkGeneric
11/2021 - 06/2013
4Long Noncoding RNAIBA
10/2021 - 01/2018
4Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2021 - 01/2015
4CholesterolIBA
10/2021 - 07/2012
4Cytochrome P-450 CYP3AIBA
07/2021 - 03/2011
4InterleukinsIBA
06/2021 - 06/2013
4Phenobarbital (Luminal)FDA Link
01/2021 - 01/2017
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 01/2012
4Antiviral Agents (Antivirals)IBA
01/2018 - 07/2004
4GadoliniumIBA
01/2018 - 05/2014
3NivolumabIBA
05/2024 - 03/2022
3Hematoxylin (Haematoxylon)IBA
02/2024 - 04/2011
3Therapeutic UsesIBA
02/2024 - 01/2022
3Eosine Yellowish-(YS) (Eosin)IBA
02/2024 - 04/2011
3Neuroprotective AgentsIBA
12/2023 - 02/2010
3LipidsIBA
10/2023 - 10/2012
3Nucleic AcidsIBA
08/2023 - 02/2014
3Biocompatible Materials (Biomaterials)IBA
07/2023 - 10/2020

Therapy/Procedure

41Therapeutics
04/2024 - 06/2009
21Drug Therapy (Chemotherapy)
05/2024 - 06/2012
11Radiotherapy
01/2022 - 01/2012
5Lasers (Laser)
01/2013 - 02/2002
4Transplantation
04/2024 - 04/2013
4Oral Administration
12/2022 - 06/2012
4Length of Stay
01/2022 - 12/2011
4Chemoradiotherapy
01/2022 - 11/2017
3Immunotherapy
11/2023 - 10/2019